financetom
Business
financetom
/
Business
/
Mgm Resorts Insider Sold Shares Worth $5,633,292, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Mgm Resorts Insider Sold Shares Worth $5,633,292, According to a Recent SEC Filing
Jun 14, 2024 2:44 PM

05:16 PM EDT, 06/14/2024 (MT Newswires) -- Keith A. Meister, Director, on June 13, 2024, sold 139,300 shares in Mgm Resorts ( MGM ) for $5,633,292. Following the Form 4 filing with the SEC, Meister has control over a total of 5,859,478 shares of the company, with 5,859,478 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/789570/000095017024073797/xslF345X03/ownership.xml

Price: 39.78, Change: -0.07, Percent Change: -0.18

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Update: Upstart Q4 Tops Estimates; FY25 Revenue Guidance Above Consensus; Shares Soar Premarket
Update: Upstart Q4 Tops Estimates; FY25 Revenue Guidance Above Consensus; Shares Soar Premarket
Feb 12, 2025
04:49 AM EST, 02/12/2025 (MT Newswires) -- (Updates with the stock move in the headline and the first paragraph.) Upstart Holdings ( UPST ) shares were up more than 26% in premarket activity Wednesday after the company said overnight that it swung into the black in Q4 as sales surged. Its full-year revenue guidance also beat market expectations. The company...
STAAR Surgical Swings to Loss in Fiscal Q4, Sales Drop; Plans Cost-Cutting; Shares Plunge Premarket
STAAR Surgical Swings to Loss in Fiscal Q4, Sales Drop; Plans Cost-Cutting; Shares Plunge Premarket
Feb 12, 2025
05:21 AM EST, 02/12/2025 (MT Newswires) -- STAAR Surgical ( STAA ) reported a fiscal Q4 loss late Tuesday of $0.69 per diluted share, compared with earnings of $0.16 a year earlier. Analysts polled by FactSet expected a loss of $0.18. Net sales for the quarter that ended Dec. 27 was $49 million, down from $76.3 million a year earlier....
SpringWorks Therapeutics Says Gomekli Receives FDA Approval for Genetic Disorder
SpringWorks Therapeutics Says Gomekli Receives FDA Approval for Genetic Disorder
Feb 12, 2025
04:56 AM EST, 02/12/2025 (MT Newswires) -- SpringWorks Therapeutics ( SWTX ) said late Tuesday the US Food and Drug Administration has approved Gomekli, or mirdametinib, for the treatment of certain patients with neurofibromatosis type 1, a genetic disorder with symptoms including abnormal pigmentation and tumor growth. The approval is based on findings from a phase 2b trial in which...
Lithia Motors' Q4 Adjusted Earnings Fall, Revenue Rises
Lithia Motors' Q4 Adjusted Earnings Fall, Revenue Rises
Feb 12, 2025
05:33 AM EST, 02/12/2025 (MT Newswires) -- Lithia Motors ( LAD ) reported Q4 adjusted earnings Wednesday of $7.79 per diluted share, down from $8.32 a year earlier. Analysts polled by FactSet expected $7.17. Revenue for the quarter ended Dec. 31 was $9.22 billion, compared with $7.67 billion a year earlier. Analysts surveyed by FactSet expected $9.08 billion. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved